Netherlands: WHN [World Health Network] PAIS [Post-Acute Infection Syndromes] Conference, 26th to 29th August, 2026, Amsterdam

Andy

Senior Member (Voting rights)
Link no longer works. See post #10 for up to date link.


"Join Lionhearted Science – United Against PAIS

Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most complex and urgent health challenges of our time. Their impact extends far beyond healthcare, affecting work, education, social participation and long-term wellbeing, with growing economic consequences. Despite rapidly growing scientific insight, knowledge remains fragmented across disciplines, countries and care systems. This underscores the need for structured international collaboration to integrate evidence, align clinical practice and accelerate real-world impact.

This is why the World Health Network is organizing the WHN PAIS Conference 2026."

Further details
 
Last edited by a moderator:
It's been highlighted to me that there is a

"Patient Day

On Saturday 29th August, a separate patient afternoon will be organised. Participants of the conference will provide an easy language presentation of their work. More information will follow soon!"

Link

Information elsewhere on the site states that it will be livestreamed but not whether there would be a charge for it or not.
 
Meetings like this are usually organised by companies that make money out of people wanting to 'network' for commercial reasons.

Looking at the World Health Network website it seems an odd rather amateurish looking set-up with bold goals but very little detail. I think it very likely that someone has seen this as a moneyspinner. I have o idea whether or not anybody is likely to attend.
 
Happy to see this on the website:

OUR COMMITMENT TO

HEALTH & SAFETY​

The ISLC-PAIS Conference team are committed to ensuring a safe, inclusive, and science-based environment for all attendees and speakers. We are currently in direct contact with technical partners, to hire / barter Air Disinfection Systems, and have already conducted preliminary assessments at the venue. These assessments indicate that a very high level of air renewal is possible in large parts of the building, which gives us a strong baseline to work from. In addition to ventilation capacity, we are preparing continuous indoor air quality monitoring during the conference using professional CO₂ monitoring units. These systems do not rely on large public displays, but provide real-time readings directly to designated members of the conference team via their mobile devices. Alerts are triggered if thresholds are exceeded, allowing us to immediately coordinate with the venue’s technical staff to adjust ventilation where needed. Regarding personal protective measures, we strongly encourage the use of high-quality masks in all indoor settings to help protect our community and will have a supply of high-quality masks available on site, and hand disinfectant stations will be placed throughout the venue.
 
August 26-29, 2026

Amsterdam (the Netherlands)

ISLC-PAIS Conference

Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most complex and urgent health challenges of our time. Their impact extends far beyond healthcare, affecting work, education, social participation and long-term wellbeing, with growing economic consequences. Despite rapidly growing scientific insight, knowledge remains fragmented across disciplines, countries and care systems. This underscores the need for structured international collaboration to integrate evidence, align clinical practice and accelerate real-world impact.
This is why we are organizing the ISLC-PAIS Conference 2026 in a COVID-safe environment.
 
The program has been published. Great to see so many familiar faces in Amsterdam. I was however surprised to see the AIR Amygdala Retraining pop up there as well. Claiming to improve fatigue, dysautonomia and inflammatory markers.

 
The program has been published. Great to see so many familiar faces in Amsterdam. I was however surprised to see the AIR Amygdala Retraining pop up there as well. Claiming to improve fatigue, dysautonomia and inflammatory markers.

Wasn’t the preliminary data negative?
 
I think you're talking about the trial that was part of the Long-Covid Project based in Finland:



This study is from Miami:


Ah, thank you for clearing that up.

I see they are using a waitlist control. And they had planned objective measurements. If those are not highlighted in the presentation I think we can be fairly certain they didn’t find anything.
 
Back
Top Bottom